Behcet's disease in acquired immune deficiency syndrome  by Siddiqui, Beenish et al.
IDCases 3 (2016) 3–4Case Report
Behcet’s disease in acquired immune deﬁciency syndrome
Beenish Siddiqui a, Denise Fernandes a, Benjamin Chaucer b,*, Marie Chevenon a,
Minesh Nandi a, Jessie Saverimuttu a, Jay Nfonoyim a
aRichmond University Medical Center, Department of Internal Medicine, Staten Island, NY 10310, United States
b St. Georges University School of Medicine, St. Georges, Grenada
A R T I C L E I N F O
Article history:
Received 18 October 2015
Received in revised form 14 November 2015





A B S T R A C T
HIV/AIDS patients often present with orogenital ulcers. In the immunocompromised patient diagnosis of
these ulcers pose a challenge, as there is a myriad of etiologies. We present a case of an HIV/AIDS patient
with recurrent orogenital aphthosis that was conﬁrmed to have concomitant diagnosis of Behcet’s
disease. Proper awareness of the causes of these ulcers is essential for prompt and effective treatment.
While rare causes may be at the bottom of a differential list in an immunocompetent host, when HIV/
AIDS is involved these rare causes often percolate to the top.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Behcet’s disease is a rare chronic immune-mediated small-
vessel systemic vasculitis that is characterized by a triad of oral
ulcers, genital ulcers and ocular manifestations [1]. There is
evidence to suggest that infection (viral or bacterial), as well as
genetic and environmental factors, play a role in this disease.
However, the pathophysiology of the diseases has not been clearly
identiﬁed and it may be the ﬁnal step due to a variety of different
stimuli. Behcet’s disease is rarely reported in HIV/AIDS patient [2–5].
We present such a case.
Case report
A 41 year old male, with a past medical history of HIV with no
recent CD4 count, was admitted with a several month history of
fatigue, night sweats, anorexia, painful swallowing with ulcers over
the upper lip, and painful draining ulcers in inter-gluteal fold. On
physical exam, these ulcers were noted to have a purulent discharge,
with erythema of the surrounding skin. He was also found to have
painful pretibial nodules and oral thrush. Chest examination
included normal breath sounds and regular heart sounds. The
abdominal examination was non-tender and soft with normal bowel
sounds. The initial impression was cutaneous herpes involving
perianal skin and lips, with a bacterial superinfection. Odynophagia* Corresponding author. Tel.: +1 8023497004.
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4.0/).was attributed to possible candidal esophagitis versus herpes
esophagitis. Accordingly, treatment with acyclovir, ﬂuconazole,
vancomycin and piperacillin/tazobactam was initiated.
Serologies for FTA-ABS for syphilis were found to be positive,
with an RPR titer of 1:4, and weekly treatment for latent syphilis
with benzathine penicillin was started for duration of three weeks.
Empiric treatment for Lymphogranuloma venereum (LGV) was
begun with doxycycline. CD4 count was 78, and therefore,
prophylaxis for PCP was initiated with atovaquone, as the patient
had an allergy to trimethoprim/sulfamethoxazole. At this time
HAART therapy was initiated as well. Eventually serologies for
Chlamydia trachomatis, Neisseria gonorrhoeae, LGV serology, and
acid fast smear for TB were negative.
Our patient’s condition improved with antibiotics and the
patient was discharged with antiretroviral therapy and scheduled
for a follow up as outpatient. Two months later the patient was
readmitted with perianal ulcers, and multiple painful oral ulcers.
The largest ulcer was measured at 10 mm  7 mm in diameter; at
this time a differential diagnosis of ulcers secondary to an HSV
infection and oral thrush was considered. The patient was
noncompliant with the antiretroviral medications since discharge
from the hospital. His CD4 count at this time was less than 20, HAART
medications were resumed during at admission. The patient was
started on ﬂuconazole for possible candidal esophagitis, acyclovir for
cutaneous herpes, and primary antimicrobial prophylaxis for
pneumocystosis and toxoplasmosis. Upper endoscopy was done,
and showed a large 5 cm deep ulcer in the lower esophagus.
The patient went for colonoscopy that showed active GI bleed
from the descending colon. Patient had technetium-labeled rede under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
B. Siddiqui et al. / IDCases 3 (2016) 3–44blood cell bleeding scan which was negative. Angiography was
performed which did not reveal any actively bleeding vessel but
during the procedure the patient developed massive lower
gastrointestinal bleeding, requiring 20 units of transfused blood.
He underwent subtotal colectomy with ileostomy and a PEG tube
was placed for feeding.
Biopsy of esophagus showed mild acute and chronic inﬂam-
mation. Biopsy from duodenum, stomach and esophagus was
negative for fungal elements, HSV1, HSV2, and CMV PCR. Colon
biopsy showed punched out ulcers, associated with monocytic
inﬂammation, vasculitis with thrombi, mural necrosis with
histiocytes and lymphocytes in the vascular wall. A diagnosis of
Behcet’s disease, along with Behcet’s colitis was made based on
the histopathology ﬁndings and the correlating clinical history.
Subsequently treatment with colchicine twice a day was initiated
for mucocutaneous manifestations of Behcet’s disease until
resolution of symptoms.
Discussion
Behc¸et’s disease is a rare disease that is characterized by
recurrent oral aphthae and any of several systemic manifestations,
including genital aphthae, ocular disease, skin lesions, gastroin-
testinal disease, neurologic disease, vascular disease, and arthritis.
Most clinical manifestations of Behc¸et’s disease are believed to be
due to vasculitis. The disease is remarkable for its ability to involve
blood vessels of all sizes (small, medium, and large) on both the
arterial and venous sides of the circulation [6]. Our patient had
orogenital ulcers, which initially responded well to antiretroviral
and antibacterial treatment. However, through non-compliance
with his antimicrobials, and worsening control of his HIV he
developed a recurrence of his orogenital ulcers, with ulcers and
colitis found during endoscopy and colonoscopy. The cause of
Behcet’s disease is unknown, but viral agents or autoimmune
mechanisms are currently suggested as possible important factors
in pathogenesis. Genome wide association studies have identiﬁed
HLA-B51 to be associated most strongly with disease susceptibility
[7]. Although the mechanism is still not clear to how this allele
contributes to pathogenesis in Behcet’s disease, it is hypothesized
that it plays a role in presentation of CD8+ T cells. Arterial disease
in Behcet’s disease is most commonly a small vessel vasculitis, but
medium and large vessel involvement may occur. Large vessel
vascular involvement occurs in approximately one-third of
patients with Behc¸et’s disease. In these patients, perivascular
and endovascular inﬂammation may lead to hemorrhage, stenosis,
aneurysm formation, thrombus formation in both arteries and
veins, and varices.
One of the earliest reports of Behcet’s disease occurring in an
HIV infected individual was by Buskila and colleagues in 1991
[8]. The pathophysiology of Behcet’s disease in HIV patients is still
unclear; however it is proposed that the disturbances in the
immune system caused by HIV virus may result in susceptibility to
autoimmune disease and vasculitis [9]. Considering the growing
number of cases with HIV infection and Behcet’s disease an
association seems probable. This case highlights the immunederegulation caused by HIV infection and the pathogenesis of
Behcet’s disease. Given the rarity of this presentation more
knowledge on pathogenesis, management and evolution of these
two diseases is needed. Most of the reports involve HIV infected
individuals who have not yet been treated with antiretrovirals or
have been poorly treated with low CD4 cell counts and high HIV
viral loads. Importantly, a number of reports documented that
effective antiretroviral therapy produced a remission of the signs
and symptoms of Behcet’s disease [3,4,9]. The response of HIV
infection to antiretroviral treatment is measured by the drop in
HIV viral load (virological effect) and a subsequent rise in the
number of circulating CD4 cells (immunological effect). As Behcet’s
disease is thought to be immunological in origin, it might be
thought that, in the cases of the disease associated with HIV
infection, the rise in the number of circulating CD4 cells might be
responsible for the remission of Behcet’s disease. A 1997 report
[10] investigated an individual with idiopathic CD4 T-lymphocy-
topenia (CD4 cell count 10) with a Behcet’s disease-like illness but
no other cases have been reported to our knowledge. Mercie et al.
[11] observed a relationship between Behcet’s disease activity an
increased viral load. In addition, Cicalini et al. [9] have postulated
that induction of Behcet’s disease in HIV-associated cases might be
a direct effect of viral replication or through HIV-induction of
autoimmune mechanisms. More recently, a case of Behcet’s
disease has been reported after acute HIV infection [12] when
the CD4 count was not low, further suggesting that, if there is a true
relationship, HIV replication itself could be the relevant HIV
parameter causing immune dysregulation.
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